36 KB473 KB34 KB192920262012Kores-Plesničar, BlankaPlesničar, Andrejletnik:81številka:9str. 645-652ISSN:1318-0347COBISSID:30186457URN:URN:NBN:SI:doc-B1EJX9KHslSlovensko zdravniško društvoZdravniški vestnikAdverse EffectsAntineoplastic AgentsAntineoplastikiCognition DisordersDejavniki tveganjaDrug TherapyNeoplasmsNovotvorbeRisk FactorsSpoznavne motnjetumorKemoterapija raka in kognitivne motnje| Cancer chemotherapy and cognitive dysfunction|Background: Cancer chemotherapy is associated with numerous side effects, one of them being cognitive impairment, which is poorly known and insufficiently recognised in clinical practice. Memory, concentration, attention, and executive function deficits are associated with chemotherapy, hormone therapy,and also with treatments using biological response modifiers. Cognitive disorders may be either mild or more severely pronounced, and they often prevent the patients to return to their previous level of functioning. Symptomatic treatment of these disorders is still limited; cognitive and behaviour strategies may prove beneficial, together with positive reinforcement and education. Conclusions: Cancer treatment is becoming more and more effective; therefore, quality of life and the ability to return effectively to everyday life is ever more important. Recognition of cognitive sequelae of cancer treatment and their management will thus be included in themultidisciplinary treatment of cancer patients in the futureTEXTznanstveno časopisjejournalsSlovenian National E-content AggregatorNational and University Library of SloveniaSlovensko zdravniško društvo